Table 1.
Clinical and ultrasound parameters in patients and control subjects
| Control subjects | ED patients without penile vasculopathy | ED patients with penile vasculopathy | |
|---|---|---|---|
| n | 50 | 115 | 92 |
| Age (years) | 48.2 ± 14.6 | 49.4 ± 12.5 | 58.3 ± 8.35* |
| IIEF score | 28.3 ± 1.2 | 19.8 ± 2.3 | 17.6 ± 1.6* |
| BMI | 24.7 ± 2.3 | 26.5 ± 3.3 | 27.9 ± 3.6 |
| Waist circumference (cm) | 87.0 ± 5.6 | 98.1 ± 10.7 | 110.6 ± 6.2* |
| Glycemia (mg/dL) | 88.6 ± 11.2 | 89.7 ± 25.6 | 114.5 ± 58.6* |
| HDL (mg/dL) | 47.6 ± 8.9 | 50.6 ± 12.2 | 43.7 ± 13.3* |
| Triglycerides (mg/dL) | 138.7 ± 47.6 | 114.8 ± 54.4 | 159.8 ± 122.9* |
| Arterial hypertension (%) | 14.3 | 23.4 | 61.2* |
| Metabolic syndrome (%) | 10.7 | 13.9 | 48.9* |
| Testosterone (nmol/L) | 15.6 ± 2.4 | 16.5 ± 5.6 | 14.0 ± 5.6 |
| Diabetes or glycemia >100 mg/dL (%) | 2.3 | 4.9 | 34.3* |
| HDL <40 mg/dL (%) | 12.9 | 15.6 | 30.7* |
| Triglycerides >150 mg/dL (%) | 23.7 | 25.2 | 45.2* |
| Smoking (%) | 27.1 | 28.0 | 31.8 |
| PSV (cm/s) | 62.7 ± 19.3 | 56.4 ± 16.0 | 45.8 ± 18.0* |
| IMT cavernosal (mm) | 0.17 ± 0.04 | 0.17 ± 0.05 | 0.31 ± 0.03* |
| IMT carotid (mm) | 0.62 ± 0.16 | 0.63 ± 0.19 | 0.79 ± 0.27* |
| Carotid vasculopathy (%) | 14.3 | 15.4 | 52.0* |
| IMT femoral (mm) | 0.64 ± 0.21 | 0.74 ± 0.34 | 0.93 ± 0.34* |
| Femoral vasculopathy (%) | 12.1 | 19.6 | 70.3* |
| Carotid plus femoral vasculopathy (%) | 3.2 | 9.3 | 45.7* |
*P < 0.05.